Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBS Evaluation and Treatment in Primary Care
NCT01641341Phase 4Completed
- Sponsor
- American Academy of Family Physicians
- Start
- Nov 2010
- Primary completion
- Mar 2012
- Modality
- Replacement Enzymes, Live Biotherapeutic Products, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Bifidobacterium longum subsp. infantis, pancrelipase, nitazoxanide in irritable bowel syndrome (IBS), sponsored by American Academy of Family Physicians. Started Nov 2010; status: completed.
02
Drugs
Bifidobacterium longum subsp. infantispancrelipasenitazoxanide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01641341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01641341.